For Investors

Press Releases

Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization Approval

12/03/25

Humana and UnitedHealthcare, which granted authorization in November, are the two largest Medicare Advantage providers in the U.S. , accounting for  47% of all Medicare Advantage enrollees This latest approval will help enhance timely access to cutting-edge personal exoskeleton solutions for

Read More
Read More

UnitedHealthcare Medicare Advantage Plan Issues Prior Authorization Approval for a ReWalk 7 Personal Exoskeleton

11/17/25

Approval marks continued progress in expanding reimbursement pathways and accelerating access to advanced personal exoskeleton technology for individuals with spinal cord injury. MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel , Nov. 17, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd.

Read More
Read More

Lifeward Ltd. Reports Third Quarter 2025 Financial Results

11/14/25

Record quarter of ReWalk systems placed for Medicare beneficiaries since fee schedule established  Ongoing efficiency initiatives drive 16% year-over-year decrease in quarterly cash burn and 27% decrease in quarterly Non-GAAP operating loss Entered into $3.0 million loan agreement with Oramed Ltd.

Read More
Read More

Lifeward to Report Third Quarter Financial Results on November 14, 2025

11/10/25

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel , Nov. 10, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company

Read More
Read More

First Commercial Medicare Advantage Plan Provides Payment for ReWalk 7 Personal Exoskeleton

09/09/25

Medicare Advantage claim processed in less than thirty days Additional progress with traditional Medicare claim approvals has accelerated timelines to payment in 2025 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel , Sept. 09, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd.

Read More
Read More

Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton

09/08/25

Seventh generation of industry-leading ReWalk Exoskeleton is now cleared for commercial launch in the European Union MARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. , (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical

Read More
Read More

Lifeward Ltd. Reports Second Quarter 2025 Financial Results

08/14/25

Achieves r ecord n umber of ReWalk s ystems p laced f or Medicare b eneficiaries s ince fee schedule established Third consecutive quarter of U.S. ReWalk pipeline growth   with over 130 qualified leads in process A ppoints n ew CEO and CFO to s pearhead s trategic c hange and a ccelerate g rowth

Read More
Read More

Lifeward Names Almog Adar as New CFO, Strengthening Executive Leadership

08/13/25

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel , Aug. 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that Almog Adar ,

Read More
Read More

Lifeward to Report Second Quarter Financial Results on August 14, 2025

08/07/25

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that the Company

Read More
Read More

Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region

08/04/25

Expansion adds additional AlterG dealer coverage to 6 countries throughout the Gulf Cooperation Council region MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel , Aug. 04, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. , (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical

Read More
Read More

Lifeward Announces Closing of $2.6 Million Public Offering

06/26/25

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel , June 26, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced the closing of

Read More
Read More

Lifeward Announces Pricing of $2.6 Million Public Offering

06/25/25

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel , June 25, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd. (NASDAQ: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced the pricing of a

Read More
Read More
Displaying 13 - 24 of 345